Vertex Pharmaceuticals Incorporated:企業の戦略・SWOT・財務情報

◆英語タイトル:Vertex Pharmaceuticals Incorporated - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4460
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Vertex Pharmaceuticals Incorporated – Strategy, SWOT and Corporate Finance Report
Summary

Vertex Pharmaceuticals Incorporated – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Vertex Pharmaceuticals Incorporated (Vertex or ‘the company’) is a biotechnology company engaged in the discovery, development and commercialization of new medicines. Vertex operates R&D facilities in California, Washington D.C., Iowa, Canada, Switzerland, the UK, France, Germany, Australia, Ireland, Spain, Italy and the Netherlands. The company primarily operates in the US, Canada and Europe. It is headquartered in Boston, Massachusetts.

Scope

- Detailed information on Vertex Pharmaceuticals Incorporated required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Vertex Pharmaceuticals Incorporated in the form of a SWOT analysis
- An in-depth view of the business model of Vertex Pharmaceuticals Incorporated including a breakdown and examination of key business segments
- Intelligence on Vertex Pharmaceuticals Incorporated’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Vertex Pharmaceuticals Incorporated, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Vertex Pharmaceuticals Incorporated and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vertex Pharmaceuticals Incorporated as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Vertex Pharmaceuticals Incorporated’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Vertex Pharmaceuticals Incorporated: Company Overview 9
Vertex Pharmaceuticals Incorporated: Overview and Key Facts 9
Vertex Pharmaceuticals Incorporated: Overview 9
Vertex Pharmaceuticals Incorporated: Key Facts 9
Vertex Pharmaceuticals Incorporated: Key Employees 10
Vertex Pharmaceuticals Incorporated: Key Employee Biographies 12
Vertex Pharmaceuticals Incorporated: Major Products and Services 20
Vertex Pharmaceuticals Incorporated: Company History 21
Vertex Pharmaceuticals Incorporated: Management Statement 27
Vertex Pharmaceuticals Incorporated: Locations and Subsidiaries 29
Vertex Pharmaceuticals Incorporated: Key Competitors 30
Vertex Pharmaceuticals Incorporated: Company Analysis 31
Vertex Pharmaceuticals Incorporated: Business Description 31
Vertex Pharmaceuticals Incorporated: SWOT Analysis 33
Vertex Pharmaceuticals Incorporated: SWOT Overview 33
Vertex Pharmaceuticals Incorporated: Strengths 33
Vertex Pharmaceuticals Incorporated: Weaknesses 34
Vertex Pharmaceuticals Incorporated: Opportunities 34
Vertex Pharmaceuticals Incorporated: Threats 34
Vertex Pharmaceuticals Incorporated: Corporate Financial Deals Activity 36
Vertex Pharmaceuticals Incorporated: Financial Deals Overview 36
Vertex Pharmaceuticals Incorporated: Targets and Partners 38
Vertex Pharmaceuticals Incorporated: Top Deals 2014 – 2018YTD* 39
Vertex Pharmaceuticals Incorporated: Mergers and Acquisitions 40
Vertex Pharmaceuticals Incorporated: Corporate Venturing 41
Vertex Pharmaceuticals Incorporated: Partnership 42
Vertex Pharmaceuticals Incorporated: Recent Developments 43
Vertex Pharmaceuticals Incorporated: News and Events Summary 43
Vertex Pharmaceuticals Incorporated: Business Expansion 46
Vertex Pharmaceuticals Incorporated: Corporate Governance 47
Vertex Pharmaceuticals Incorporated: Corporate Social Responsibility 47
Vertex Pharmaceuticals Incorporated: Financial Performance 49
Vertex Pharmaceuticals Incorporated: Grants 50
Vertex Pharmaceuticals Incorporated: Strategy and Operations 51
Appendix 52
Contact Us 52
Methodology 52
About MarketLine 53

List of Tables
Table 1: Vertex Pharmaceuticals Incorporated: Key Facts
Table 2: Vertex Pharmaceuticals Incorporated: Key Employees
Table 3: Vertex Pharmaceuticals Incorporated: Locations and Subsidiaries
Table 4: Vertex Pharmaceuticals Incorporated: Key Competitors
Table 5: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Vertex Pharmaceuticals Incorporated: M&A Average Deal Size - Value (US$m)
Table 8: Vertex Pharmaceuticals Incorporated: Targets and Partners
Table 9: Vertex Pharmaceuticals Incorporated: Top Deals 2014 - 2018YTD*
Table 10: Vertex Pharmaceuticals Incorporated: M&A Volume and Value Trend (2014 - YTD*2018)
Table 11: Vertex Pharmaceuticals Incorporated: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 12: Vertex Pharmaceuticals Incorporated: Corporate Venturing by Geography (2014 - YTD*2018)
Table 13: Vertex Pharmaceuticals Incorporated: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 14: Vertex Pharmaceuticals Incorporated: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 15: Vertex Pharmaceuticals Incorporated: News and Events Summary
Table 16: Vertex Pharmaceuticals Incorporated: Business Expansion
Table 17: Vertex Pharmaceuticals Incorporated: Corporate Governance
Table 18: Vertex Pharmaceuticals Incorporated: Corporate Social Responsibility
Table 19: Vertex Pharmaceuticals Incorporated: Financial Performance
Table 20: Vertex Pharmaceuticals Incorporated: Grants
Table 21: Vertex Pharmaceuticals Incorporated: Strategy and Operations

List of Figures
Figure 1: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Vertex Pharmaceuticals Incorporated: M&A Average Deal Size - Value (US$m)
Figure 4: Vertex Pharmaceuticals Incorporated: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Vertex Pharmaceuticals Incorporated: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 6: Vertex Pharmaceuticals Incorporated: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 7: Vertex Pharmaceuticals Incorporated: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 8: Vertex Pharmaceuticals Incorporated: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Vertex Pharmaceuticals Incorporated:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Texwinca Holdings Limited:企業の戦略・SWOT・財務情報
    Texwinca Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Texwinca Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Vexim SA (ALVXM):企業の財務・戦略的SWOT分析
    Summary Vexim SA (Vexim), a subsidiary of Stryker Corp, is a healthcare product manufacturer that provides solutions for patients suffering from vertebral compression fractures. The company provides solutions such as controlled anatomical restoration and advanced vertebroplasty therapy. Its controll …
  • UK Mail Group Plc (UKM):企業の財務・戦略的SWOT分析
    UK Mail Group Plc (UKM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Daily Mail & General Trust plc (DMGT):企業の財務・戦略的SWOT分析
    Daily Mail & General Trust plc (DMGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • MGC Diagnostics Corp (MGCD):企業の財務・戦略的SWOT分析
    Summary MGC Diagnostics Corp (MGC Diagnostics) is a medical device company that provides cardio respiratory health solutions. The company provides PFT, metabolic CPET and CPX and indirect calorimetry products. Its PFT products include plethysmograph, pulmonary function systems, spirometry and forced …
  • Micell Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Micell Technologies Inc (Micell) is a medical device company that develops drug delivery systems for the treatment of cardiovascular diseases. The company provides product such as MiStent sirolimus eluting absorbable polymer coronary stent system, a drug-eluting stent that is designed to opt …
  • China Resources Power Holdings Co Ltd:企業の発電所・SWOT分析2018
    China Resources Power Holdings Co Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • Rubis SCA (RUI):企業の財務・戦略的SWOT分析
    Rubis SCA (RUI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Hitachi Zosen Corporation:企業の戦略・SWOT・財務分析
    Hitachi Zosen Corporation - Strategy, SWOT and Corporate Finance Report Summary Hitachi Zosen Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Scapa Group plc (SCPA):企業の財務・戦略的SWOT分析
    Scapa Group plc (SCPA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Phoenix Beverages Limited:戦略・SWOT・企業財務分析
    Phoenix Beverages Limited - Strategy, SWOT and Corporate Finance Report Summary Phoenix Beverages Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Termas De Puyehue S.A.:企業の戦略・SWOT・財務分析
    Termas De Puyehue S.A. - Strategy, SWOT and Corporate Finance Report Summary Termas De Puyehue S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Siam Makro Public Company Limited (MAKRO):企業の財務・戦略的SWOT分析
    Siam Makro Public Company Limited (MAKRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Greif, Inc.:企業の戦略・SWOT・財務分析
    Greif, Inc. - Strategy, SWOT and Corporate Finance Report Summary Greif, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Public Financial Holdings Limited (626):企業の財務・戦略的SWOT分析
    Public Financial Holdings Limited (626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • mBio Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary MBio Diagnostics Inc (MBio) is a medical device company that offers clinical diagnostics and sample testing solutions. The company offers MBio multiplex analyzer and disposable cartridges. Its MBio Array System is a fluorescence immunoassay system that provides measurement of analytes from a …
  • Parkway Pantai Ltd:企業の戦略的SWOT分析
    Parkway Pantai Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Novozymes AS (NZYM B):製薬・医療:M&Aディール及び事業提携情報
    Summary Novozymes AS (Novozymes) is a biotech company that produces, markets and sells a range of industrial enzymes and microorganisms. The company provides enzymes for detergents, technical, food and feed industries. It supplies a range of microorganisms for use in agriculture, industrial cleaning …
  • C&J Energy Services Inc (CJ):企業の財務・戦略的SWOT分析
    C&J Energy Services Inc (CJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • LifeScan Inc:医療機器:M&Aディール及び事業提携情報
    Summary LifeScan Inc (LifeScan), a subsidiary of the Johnson & Johnson, develops, manufactures and markets blood glucose monitoring solutions for hospital and home use. The company’s product portfolio includes blood glucose meters; test strips and control solutions; lancing devices; diabetes managem …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆